... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2025 Circulating tumor DNA Bladder cancer Prognostic assessment Meta-analysis Biomarker Bladder cancer is one of the most common malignant tumors of the urinary...

... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2025 SIRT7 Upper tract urothelial carcinoma Adjuvant chemotherapy Immunotherapy Biomarker Upper tract urothelial carcinoma (UTUC) is a relatively rare tumor type, derived...

..., p = 0.0005). Conclusion: Low CCNA2 expression is significantly associated with worse OS. Thus, CCNA2 might serve as a potential biomarker in muscle-invasive UTUC and may be used to characterize a subset of patients having an unfavorable outcome and for future risk assessment scores...

...) and progression groups (p = 0.216). Conclusion: For patients with intermediate- and high-risk NMIBC, serum SII levels do not present as an appropriate biomarker for the prediction of disease recurrence and progression following intravesical BCG therapy. A possible explanation for the failure of SII to predict BCG...

..., quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2022 Numerous molecular biomarkers for bladder cancer diagnosis...

... provided in the kit, the cells were analyzed using a flow cytometer (BD FACSAria III; Pudong, Shanghai, China). Long noncoding RNA long intergenic noncoding RNA 00707 miR-145 Bladder cancer Metastasis Biomarker Cell division cycle associated 3 Bladder cancer (BC) ranks the fifth most...

...Klaus-Peter Dieckmann; Finja Hennig; Petra Anheuser; Ralf Gehrckens; Florian Viehweger; Christian Wülfing; Gazanfer Belge Background: MicroRNA-371a-3p (miR-371), the novel serum biomarker of testicular germ cell tumours (GCTs), is produced by undifferentiated subtypes of GCTs but not by teratoma...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Low-molecular-weight protein tyrosine phosphatase Metastatic hormone-naïve prostate cancer Biomarker Androgen...

... of the authors has declared conflicts of interest with the present manuscript. This study did not receive any funding from external sources. References 1. Mir MC, Pavan N, Gonzalgo ML: Current clinical applications of testicular cancer biomarkers. Urol Clin North Am 2016;43:119-125. 2. Murray MJ...

...Petra Anheuser; Arlo Radtke; Christian Wülfing; Jennifer Kranz; Gazanfer Belge; Klaus-Peter Dieckmann Introduction: MicroRNA (miR)371a-3p was suggested to be a sensitive and specific new serum biomarker of germ cell tumours (GCTs); however, its clinical usefulness remains unproven. Patients...

...Klaus-Peter Dieckmann; Meike Spiekermann; Thomas Balks; Raphael Ikogho; Petra Anheuser; Werner Wosniok; Thomas Loening; Jörn Bullerdiek; Gazanfer Belge Background: microRNAs (miRs)-371-3 are suggested to be novel biomarkers of germ cell tumors (GCTs), but their specificity is unresolved. We aimed...

... Biomarker Modified cell metabolism is a vital component for cancer cells. MF is an anti-diabetic drug which - besides improving glycaemic control - alters multiple pathways in benign and transformed cells leading to the inhibition of proliferation, cell cycle arrest and apoptosis [ 1,2,3...

... biomarker for predicting clinical outcome of CCRCC. [email protected] 22 04 2014 1 07 2014 7 8 2014 73 pairs of CCRCC specimens and adjacent non-tumor renal tissue were fixed in 10% formaldehyde solution and embedded in blocks of paraffin. Following routine histopathological...

... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Prostate cancer Biopsy Biomarker Prostate-specific antigen proPSA Prostate-specific antigen isoform In Europe, prostate cancer (PCa...

... is a useful biomarker for monitoring the clinical course for a limited number of RCC patients, but is not a marker for diagnosis and staging. Concentrations of CK-B in RCC tissues were significantly lower than those of normal kidney. A high rate of cell turnover in tumor tissues might entail the higher level...